• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当白细胞介素-3和单一趋化因子与O-硫酸化硫酸乙酰肝素结合时,人长期培养启动细胞(LTC-IC)可在体外维持至少5周:硫酸乙酰肝素与早期作用细胞因子和基质蛋白的最佳结合相互作用的要求。

Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins.

作者信息

Gupta P, Oegema T R, Brazil J J, Dudek A Z, Slungaard A, Verfaillie C M

机构信息

Department of Medicine, Veterans Affairs Medical Center Minneapolis, MN 55417, USA.

出版信息

Blood. 2000 Jan 1;95(1):147-55.

PMID:10607697
Abstract

We have shown that stromal O-sulfated heparan sulfate glycosaminoglycans (O-S-GAGs) regulate primitive human hematopoietic progenitor cell (HPC) growth and differentiation by colocalizing heparin-binding cytokines and matrix proteins with HPC in stem cell "niches" in the marrow microenvironment. We now show that long-term culture-initiating cells (LTC-IC) are maintained for 5 weeks in the absence of stroma when O-S-GAGs are added to IL-3 and either MIP-1alpha or PF4 (LTC-IC maintenance without GAGs, 32 +/- 2%; with GAGs, 95 +/- 7%; P <.001). When cultured with 5 additional cytokines, O-S-GAGs, IL-3, and MIP-1alpha, LTC-IC expanded 2- to 4-fold at 2 weeks, and 92 +/- 8% LTC-IC were maintained at 5 weeks. Similar results were seen when PF4 replaced MIP-1alpha. Although O-S-GAG omission did not affect 2-week expansion, only 20% LTC-IC were maintained for 5 weeks. When O-S-heparin was replaced by completely desulfated-, N-sulfated (O-desulfated), or unmodified heparins, LTC-IC maintenance at week 5 was not better than with cytokines alone. Unmodified- and O-S-heparin, but not desulfated- or N-sulfated heparin, bound to MIP-1alpha, IL-3, PF4, VEGF, thrombospondin, and fibronectin. However, the affinity of heparin for thrombospondin and PF4, and the association and dissociation rates of heparin for PF4, were higher than those of O-S-heparin. We conclude that (i) although cytokines may suffice to induce early expansion, adult human LTC-IC maintenance for longer than 1 month requires O-S-GAGs, and (ii) HPC support may depend not only on the ability of GAGs to bind proteins, but also on optimal affinity and kinetics of interactions that affect presentation of proteins in a biologically active manner to progenitors. (Blood. 2000;95:147-155)

摘要

我们已经表明,基质O-硫酸化硫酸乙酰肝素糖胺聚糖(O-S-GAGs)通过将肝素结合细胞因子和基质蛋白与造血祖细胞(HPC)在骨髓微环境的干细胞“龛”中共定位,来调节原始人类造血祖细胞的生长和分化。我们现在表明,当将O-S-GAGs添加到IL-3以及MIP-1α或PF4中时,长期培养起始细胞(LTC-IC)在无基质的情况下可维持5周(无GAGs时LTC-IC维持率为32±2%;有GAGs时为95±7%;P<.001)。当与另外5种细胞因子、O-S-GAGs、IL-3和MIP-1α一起培养时,LTC-IC在2周时扩增了2至4倍,并且在5周时92±8%的LTC-IC得以维持。当用PF4替代MIP-1α时也观察到了类似结果。虽然省略O-S-GAGs不影响2周时的扩增,但只有20%的LTC-IC能维持5周。当O-S-肝素被完全去硫酸化的、N-硫酸化的(O-去硫酸化的)或未修饰的肝素替代时,第5周时LTC-IC的维持情况并不比单独使用细胞因子时更好。未修饰的和O-S-肝素能结合MIP-1α、IL-3、PF4、VEGF、血小板反应蛋白和纤连蛋白,但去硫酸化的或N-硫酸化的肝素则不能。然而,肝素对血小板反应蛋白和PF4的亲和力,以及肝素与PF4的结合和解离速率,均高于O-S-肝素。我们得出结论:(i)虽然细胞因子可能足以诱导早期扩增,但成人人类LTC-IC维持超过1个月需要O-S-GAGs;(ii)造血祖细胞的支持可能不仅取决于GAGs结合蛋白质的能力,还取决于以生物活性方式影响蛋白质向祖细胞呈递的最佳亲和力和相互作用动力学。(《血液》。2000年;95:147 - 155)

相似文献

1
Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins.当白细胞介素-3和单一趋化因子与O-硫酸化硫酸乙酰肝素结合时,人长期培养启动细胞(LTC-IC)可在体外维持至少5周:硫酸乙酰肝素与早期作用细胞因子和基质蛋白的最佳结合相互作用的要求。
Blood. 2000 Jan 1;95(1):147-55.
2
Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche.结构特异性硫酸乙酰肝素通过形成多分子干细胞生态位来支持原始人类造血。
Blood. 1998 Dec 15;92(12):4641-51.
3
A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.一种使用基质条件培养基对长期培养启动细胞(LTC-IC)和集落形成细胞(CFC)进行临床适用的体外扩增培养系统。
Exp Hematol. 1997 Aug;25(9):980-91.
4
Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells.细胞因子介导的人长期培养起始细胞体外维持需要基质成纤维细胞硫酸乙酰肝素。
Blood. 1996 Apr 15;87(8):3229-36.
5
Ex vivo culture of CD34+/Lin-/DR- cells in stroma-derived soluble factors, interleukin-3, and macrophage inflammatory protein-1alpha maintains not only myeloid but also lymphoid progenitors in a novel switch culture assay.在基质衍生的可溶性因子、白细胞介素-3和巨噬细胞炎性蛋白-1α中对CD34+/Lin-/DR-细胞进行体外培养,在一种新型的转换培养试验中不仅能维持髓系祖细胞,还能维持淋巴系祖细胞。
Blood. 1998 Jun 15;91(12):4516-22.
6
Stromal factors support the expansion of the whole hemopoietic spectrum from bone marrow CD34+DR- cells and of some hemopoietic subsets from CD34+ and CD34+DR+ cells.基质因子支持来自骨髓CD34+DR-细胞的整个造血谱系的扩增,以及来自CD34+和CD34+DR+细胞的一些造血亚群的扩增。
Leukemia. 1998 May;12(5):735-45. doi: 10.1038/sj.leu.2400924.
7
Identification of an MIP-1alpha -binding heparan sulfate oligosaccharide that supports long-term in vitro maintenance of human LTC-ICs.一种支持人长期体外维持长期培养启动细胞(LTC-ICs)的与巨噬细胞炎性蛋白-1α(MIP-1α)结合的硫酸乙酰肝素寡糖的鉴定。
Blood. 2003 Mar 15;101(6):2243-5. doi: 10.1182/blood-2002-08-2588. Epub 2002 Oct 24.
8
Macrophage inflammatory protein 1 alpha, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro.巨噬细胞炎性蛋白1α、白细胞介素3和可扩散骨髓基质因子可使人类造血干细胞在体外维持至少8周。
J Exp Med. 1994 Feb 1;179(2):643-9. doi: 10.1084/jem.179.2.643.
9
Bone marrow stromal proteoglycans regulate megakaryocytic differentiation of human progenitor cells.骨髓基质蛋白聚糖调节人类祖细胞的巨核细胞分化。
Exp Cell Res. 2004 Oct 1;299(2):383-92. doi: 10.1016/j.yexcr.2004.06.018.
10
[Protection of hematopoietic stem cells by MIP-1alpha and PF4 against the cytotoxicity of chemotherapeutic agents].
Zhonghua Xue Ye Xue Za Zhi. 2000 Jul;21(7):355-8.

引用本文的文献

1
Heparan sulfates and heparan sulfate proteoglycans in hematopoiesis.肝素硫酸和肝素硫酸蛋白聚糖在造血中的作用。
Blood. 2024 Jun 20;143(25):2571-2587. doi: 10.1182/blood.2023022736.
2
The extracellular matrix of hematopoietic stem cell niches.造血干细胞龛细胞外基质。
Adv Drug Deliv Rev. 2022 Feb;181:114069. doi: 10.1016/j.addr.2021.114069. Epub 2021 Nov 25.
3
Syndecan-2 enriches for hematopoietic stem cells and regulates stem cell repopulating capacity.Syndecan-2 富集造血干细胞并调节干细胞的再生能力。
Blood. 2022 Jan 13;139(2):188-204. doi: 10.1182/blood.2020010447.
4
Distinct Bone Marrow Sources of Pleiotrophin Control Hematopoietic Stem Cell Maintenance and Regeneration.不同骨髓来源的外泌体对造血干细胞的维持和再生的调控作用
Cell Stem Cell. 2018 Sep 6;23(3):370-381.e5. doi: 10.1016/j.stem.2018.07.003. Epub 2018 Aug 9.
5
In vitro and in vivo evaluation of cord blood hematopoietic stem and progenitor cells amplified with glycosaminoglycan mimetic.用糖胺聚糖模拟物扩增的脐带血造血干细胞和祖细胞的体外和体内评估
Stem Cell Res Ther. 2016 Jan 7;7:3. doi: 10.1186/s13287-015-0267-y.
6
Effects of simian betaretrovirus serotype 1 (SRV1) infection on the differentiation of hematopoietic progenitor cells (CD34+) derived from bone marrow of rhesus macaques (Macaca mulatta).猴β逆转录病毒1型(SRV1)感染对恒河猴(猕猴)骨髓来源的造血祖细胞(CD34+)分化的影响。
Comp Med. 2012 Feb;62(1):61-8.
7
Differential effects of HOXB4 and NUP98-HOXA10hd on hematopoietic repopulating cells in a nonhuman primate model.HOXB4 和 NUP98-HOXA10hd 对非人灵长类动物模型中造血重编程细胞的差异影响。
Hum Gene Ther. 2011 Dec;22(12):1475-82. doi: 10.1089/hum.2011.100. Epub 2011 Sep 6.
8
Covalently immobilized glycosaminoglycans enhance megakaryocyte progenitor expansion and platelet release.共价固定糖胺聚糖可增强巨核细胞祖细胞的扩增和血小板释放。
J Biomed Mater Res A. 2011 Mar 15;96(4):682-92. doi: 10.1002/jbm.a.33024. Epub 2011 Jan 25.
9
The effect of human bone marrow stroma-derived heparan sulfate on the ex vivo expansion of human cord blood hematopoietic stem cells.人骨髓基质来源硫酸乙酰肝素对人脐血造血干细胞体外扩增的影响。
Pharm Res. 2011 Jun;28(6):1385-94. doi: 10.1007/s11095-010-0352-y. Epub 2010 Dec 24.
10
Application of proteoglycan extracted from the nasal cartilage of salmon heads for ex vivo expansion of hematopoietic progenitor cells derived from human umbilical cord blood.从鲑鱼头鼻软骨中提取的蛋白聚糖在人脐带血来源的造血祖细胞体外扩增中的应用。
Glycoconj J. 2007 Jul;24(4-5):251-8. doi: 10.1007/s10719-007-9033-4. Epub 2007 Mar 28.